• Article  

      Direct evidence for normalization of platelet function resulting from platelet count reduction in essential thrombocythemia 

      Tsantes, Argirio E.; Nikolopoulos, Georgios K.; Tsirigotis, P.; Zoi, K.; Zomas, A.; Kapsimali, Violetta; Kopterides, Petros; Chondropoulos, Spyros; Dervenoulas, John; Mantzios, Georgios P. (2011)
      Essential thrombocythemia is characterized by persistent elevation and functional disturbances of platelets. Both the platelet function analyzer-100 (PFA-100) collagen-epinephrine (CEPI) cartridge and aggregometry with ...
    • Article  

      Primary extranodal non Hodgkin's lymphoma of the head and neck in adults: A clinicopathological comparison between tonsillar and non tonsillar lymphomas 

      Economopoulos, T.; Fountzilas, George; Kostourou, A.; Daniilidis, J.; Pavlidis, Nicholas; Andreopoulou, E.; Nicolaou, A.; Papageorgiou, E.; Mellou, S.; Dervenoulas, John; Stathakis, N. (1998)
      Primary extranodal NHL of the head and neck (HN-NHL) accounts for 10-20% of all cases of NHL. Despite their frequency, the natural history and biological behaviour of these lymphomas is poorly understood. In this study we ...
    • Article  

      Primary extranodal non-hodgkin's lymphoma of the head and neck 

      Economopoulos, T.; Asprou, N.; Stathakis, N.; Fountzilas, George; Pavlidis, Nicholas; Papaspyrou, S.; Dervenoulas, John; Belia, M.; Papageorgiou, E.; Theoharis, D.; Vrettou, E.; Raptis, S. (1992)
      Among 387 cases of non-Hodgkin's lymphoma (NHL) treated in our units between January 1977 and December 1990, 52 (13.4%) had primary extranodal (PE) NHL of the head and neck. The median age was 55 years with a M:F ratio of ...
    • Article  

      Second malignancies following treatment for Hodgkin's disease: A Greek experience 

      Economopoulos, T.; Stathakis, N.; Alexopoulos, C.; Pavlidis, Nicholas; Constantinidou, M.; Briassoulis, E. Ch; Papageorgiou, E.; Dervenoulas, John; Pappa, Vassiliki; Vaslamatzis, M.; Raptis, S. (1994)
      The risk and the type of second malignancies (SM) developing in 217 treated Hodgkin's disease (HD) patients were studied. The median age of the patients was 35 years (range 14-83) and the M/F ratio 1.8. Treatment consisted ...